Journal article icon

Journal article

DOPS adjuvant confers enhanced protection against malaria for VLP-TRAP based vaccines

Abstract:

Vaccination remains the most effective and essential prophylactic tool against infectious diseases. Enormous efforts have been made to develop effective vaccines against malaria but successes remain so far limited. Novel adjuvants may offer a significant advantage in the development of malaria vaccines, in particular if combined with inherently immunogenic platforms, such as virus-like particles (VLP). Dioleoyl phosphatidylserine (DOPS), which is expressed on the outer surface of apoptotic ce...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.3390/diseases6040107

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM
Sub department:
Jenner Institute
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM
Sub department:
Jenner Institute
Role:
Author
More from this funder
Name:
Bencard Adjuvant Systems
Grant:
R43086/CN001
More from this funder
Name:
Swiss National Science Foundation
Grant:
31003A_149925
Publisher:
MDPI
Journal:
Diseases More from this journal
Volume:
6
Issue:
4
Article number:
107
Publication date:
2018-11-21
Acceptance date:
2018-11-16
DOI:
ISSN:
2079-9721
Language:
English
Keywords:
Pubs id:
pubs:955418
UUID:
uuid:fde3abbb-98e2-402c-817d-9270694cc061
Local pid:
pubs:955418
Source identifiers:
955418
Deposit date:
2019-01-02

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP